Study groups | |||
Essential hypertension | Nephroangiosclerosis | ||
(n = 142) | (n = 23) | ||
Characteristics: | |||
Age (years): | 40 ± 4 | 39 ± 4 | |
Gender (F/M): | 48/94 | 8/15 | |
Duration of hypertension (months): | 4 ± 2 | 4 ± 1 | |
Duration of follow up (months): | 94 ± 12 | 93 ± 13 | |
Changes in renal function: | |||
Initial: | |||
Serum creatinine (umol/L): | 74 ± 12 | 153 ± 9 | |
Proteinuria (mg/day): | 126 ± 18 | 932 ± 195 | |
Creatinine clearance (ml/minute) | 108 ± 6 | 38 ± 4 | |
Final: | |||
Serum creatinine (umol/L): | 75 ± 11 | 437 ± 138 | |
Proteinuria (mg/day): | 129 ± 19 | 1941 ± 343 | |
Creatinine clearance (ml/minute) | 107 ± 6 | 13 ± 4 | |
Doubling of: | |||
Serum creatinine: | None | All | |
Proteinuria: | None | All | |
ESRD: | 0 | 3 |